Screening Prognosis-Related lncRNAs Based on WGCNA to Establish a New Risk Score for Predicting Prognosis in Patients with Hepatocellular Carcinoma

被引:7
|
作者
Zhou, Xueliang [1 ]
Dou, Mengmeng [2 ]
Liu, Zaoqu [1 ]
Jiao, Dechao [1 ]
Li, Zhaonan [1 ]
Chen, Jianjian [1 ]
Li, Jing [1 ]
Yao, Yuan [1 ]
Li, Lifeng [3 ]
Li, Yahua [1 ]
Han, Xinwei [1 ]
机构
[1] Zhengzhou Univ, Dept Intervent Radiol, Affiliated Hosp 1, Zhengzhou, Peoples R China
[2] Zhengzhou Univ, Dept Neurol, Affiliated Hosp 1, Zhengzhou, Peoples R China
[3] Zhengzhou Univ, Dept Oncol, Affiliated Hosp 1, Zhengzhou, Peoples R China
关键词
LONG NONCODING RNA; CANCER; MICRORNAS; IDENTIFICATION; PROLIFERATION; METASTASIS; BIOMARKERS; APOPTOSIS; DIAGNOSIS; PATHWAYS;
D O I
10.1155/2021/5518908
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. Hepatocellular carcinoma (HCC) remains an important cause of cancer death. The molecular mechanism of hepatocarcinogenesis and prognostic factors of HCC have not been completely uncovered. Methods. In this study, we screened out differentially expressed lncRNAs (DE lncRNAs), miRNAs (DE miRNAs), and mRNAs (DE mRNAs) by comparing the gene expression of HCC and normal tissue in The Cancer Genome Atlas (TCGA) database. DE mRNAs were used to perform Gene Ontology (GO), Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis. Then, the miRNA and lncRNA/mRNA modules that were most closely related to the survival time of patients with HCC were screened to construct a competitive endogenous RNA (ceRNA) network by weighted gene coexpression network analysis (WGCNA). Moreover, univariable Cox regression and Kaplan-Meier curve analyses of DE lncRNAs and DE mRNAs were conducted. Finally, the lasso-penalized Cox regression analysis and nomogram model were used to establish a new risk scoring system and predict the prognosis of patients with liver cancer. The expression of survival-related DE lncRNAs was verified by qRT-PCR. Results. A total of 1896 DEmRNAs, 330 DElncRNAs, and 76 DEmiRNAs were identified in HCC and normal tissue samples. Then, the turquoise miRNA and turquoise lncRNA/mRNA modules that were most closely related to the survival time of patients with HCC were screened to construct a ceRNA network by WGCNA. In this ceRNA network, there were 566 lncRNA-miRNA-mRNA regulatory pairs, including 30 upregulated lncRNAs, 16 downregulated miRNAs, and 75 upregulated mRNAs. Moreover, we screened out 19 lncRNAs and 14 hub mRNAs related to prognosis from this ceRNA network by univariable Cox regression and Kaplan-Meier curve analyses. Finally, a new risk scoring system was established by selecting the optimal risk lncRNAs from the 19 prognosis-related lncRNAs through lasso-penalized Cox regression analysis. In addition, we established a nomogram model consisting of independent prognostic factors to predict the survival rate of HCC patients. Finally, the correlation between the risk score and immune cell infiltration and gene set enrichment analysis were determined. Conclusions. In conclusion, the results may provide potential biomarkers or therapeutic targets for HCC and the establishment of the new risk scoring system and nomogram model provides the new perspective for predicting the prognosis of HCC.
引用
收藏
页数:20
相关论文
共 50 条
  • [31] Identification and validation of PANoptosis-related LncRNAs prognosis system in hepatocellular carcinoma
    Shu, Qi
    Zhu, Junfeng
    Mo, Jiaping
    Wei, Xiaoyan
    Zhu, Zhenjie
    Chen, Xiaojuan
    He, Fugen
    Zhong, Like
    SCIENTIFIC REPORTS, 2025, 15 (01):
  • [32] Unlocking the future of hepatocellular carcinoma treatment: A comprehensive analysis of disulfidptosis-related lncRNAs for prognosis and drug screening
    Wang, Haojun
    Wang, Wei
    OPEN MEDICINE, 2024, 19 (01):
  • [33] A GenomicInstability-Related LongNoncodingRNASignature for Predicting Hepatocellular Carcinoma Prognosis
    Lu, Jing
    Cao, Wanyue
    He, Zeping
    Wang, Haoyu
    Hao, Jialing
    Xu, Junming
    JOURNAL OF ONCOLOGY, 2022, 2022
  • [34] A necroptosis -related signature for predicting prognosis and immunotherapy in hepatocellular carcinoma
    Fu, Xing
    Yang, Yuling
    Zhang, Xiaozhi
    FRONTIERS IN GENETICS, 2022, 13
  • [35] CDC20 May Serve as a Potential Biomarker-Based Risk Score System in Predicting the Prognosis of Patients with Hepatocellular Carcinoma
    Peng, Qiliu
    Huang, Hai
    Zhu, Chunling
    Hou, Qingqing
    Wei, Shangmou
    Xiao, Yi
    Zhang, Zhi
    Sun, Xing
    Oxidative Medicine and Cellular Longevity, 2022, 2022
  • [36] RNA binding protein-based risk score model for prognosis prediction of patients with hepatocellular carcinoma
    Xu, Shengjun
    Ding, Ning
    Zheng, Sheng
    Chen, Jun
    Wan, Yafeng
    Ling, Sunbin
    Xu, Xiao
    CHINESE MEDICAL JOURNAL, 2022, 135 (23) : 2890 - 2892
  • [37] RNA binding protein-based risk score model for prognosis prediction of patients with hepatocellular carcinoma
    Xu Shengjun
    Ding Ning
    Zheng Sheng
    Chen Jun
    Wan Yafeng
    Ling Sunbin
    Xu Xiao
    中华医学杂志英文版, 2022, 135 (23)
  • [38] A three-mRNA status risk score has greater predictive ability compared with a lncRNA-based risk score for predicting prognosis in patients with hepatocellular carcinoma
    Zhang, Wenxia
    Fu, Qiang
    Yao, Kanyu
    ONCOLOGY LETTERS, 2020, 20 (04)
  • [39] Screening of Prognosis-Related Genes in Primary Breast Carcinoma Using Genomic Expression Data
    Gu, Yifan
    Chen, Guoqing
    Du, Yibao
    JOURNAL OF COMPUTATIONAL BIOLOGY, 2020, 27 (07) : 1030 - 1040
  • [40] Chromosome copy number analysis in screening for prognosis-related genomic regions in colorectal carcinoma
    Kurashina, Kentaro
    Yamashita, Yoshihiro
    Ueno, Toshihide
    Koinuma, Koji
    Ohashi, Jun
    Horie, Hisanaga
    Miyakura, Yasuyuki
    Hamada, Toru
    Haruta, Hidenori
    Hatanaka, Hisashi
    Soda, Manabu
    Choi, Young Lim
    Takada, Shuji
    Yasuda, Yoshikazu
    Nagai, Hideo
    Mano, Hiroyuki
    CANCER SCIENCE, 2008, 99 (09) : 1835 - 1840